Presented by Fox Chase Cancer Center, the Temple Lung Center, and the Temple Health Office for Continuing Medical Education, this conference is designed as a forum for discussion of advances in technology and treatment of early stage non-small cell lung cancer. Multidisciplinary perspectives, including medical, surgical and radiation oncology, pulmonology and radiology will be presented.

Details

Thursday, October 20, 2022 | 6–9 PM
6:00–7:00 pm Reception
7:00–9:00 pm CME & Dinner

Philadelphia Marriott Old City
One Dock Street
Philadelphia, PA 19106

Program Directors

Hossein Borghaei, DO, MS
Chief, Division of Thoracic Medical Oncology; Professor, Department of Hematology/Oncology; Co-Director, Immune Monitoring Facility; Gloria and Edmund M. Dunn Chair in Thoracic Oncology, Fox Chase Cancer Center

Joseph Friedberg, MD, FACS
Thoracic Surgeon-in-Chief, Temple University Health System; Vice Chair, Surgical Services, Department of Thoracic Medicine and Surgery; Co-Director, Temple-Fox Chase Cancer Center Mesothelioma and Pleural Disease Program; Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

Presenters and Topics

Evaluation of a Surgical Patient
Gerard J. Criner, MD, FACP, FACCP
Director, Temple Lung Center; Founding Chair and Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University;

Adjuvant Chemo/IO/Targeted Therapies
Martin J. Edelman, MD
Chair and Professor, Department of Hematology/Oncology; Deputy Cancer Center Director for Clinical Research; G. Morris Dorrance Jr. Chair in Medical Oncology, Fox Chase Cancer Center

Radiation and Early Stage Lung Cancer
Sameera Kumar, MD
Assistant Professor, Department of Radiation Oncology, Fox Chase Cancer Center

Radiological Evaluation of the Surgical Patient with CT/PET
Maruti Kumaran, MD, MBBS, FRCR
Associate Professor, Radiology, Lewis Katz School of Medicine at Temple University

Bronchoscopy and EBUS for Diagnosis and Staging
Christopher J. Manley, MD
Director, Interventional Pulmonology; Associate Professor, Department of Medicine, Fox Chase Cancer Center

Surgical Approaches
Whitney Burrows, MD
Associate Professor of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

Neoadjuvant Chemo-IO
Joseph Treat, MD
Professor, Department of Hematology/Oncology; Vice Chair, Education; Medical Director, Ambulatory Care, Fox Chase Cancer Center

Multidisciplinary Panel Discussion
Joseph Friedberg, MD, FACS
Thoracic Surgeon-in-Chief, Temple University Health System; Vice Chair, Surgical Services, Department of Thoracic Medicine and Surgery; Co-Director, Temple-Fox Chase Cancer Center Mesothelioma and Pleural Disease Program; Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

Registration Deadline: Tuesday, October 18, 2022

Inquiries

Lucía Tono, PhD, MEd: 215-728-3797
Lucia.Tono-Ramirez@tuhs.temple.edu

Objectives

• Identify patients who might benefit from neoadjuvant chemo-immunotherapy with early stage lung cancer
• Discuss surgical issues related to this approach
• Explain the role of biomarker testing in this setting

Intended Audience

Medical, surgical and radiation oncologists; thoracic and general surgeons; pulmonologists; gastroenterologists; pathologists; radiologists; primary care physicians; fellows/residents/students; nurses; physician assistants; and advanced practice clinicians involved in the management of patients with lung cancer and thoracic malignancies.

Accreditation Statement

The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. Fox Chase Cancer Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.

Fox Chase Cancer Center designates this live activity for a maximum of 2 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.